John Kovach

Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ.

Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY.

Mill Creek Life Sciences LLC engages in the provision of tools and technologies for therapy. It focuses on the development and application of cellular and biologic therapeutics. Its products include PLTGold and PLTMax. The company was founded by Steven L. Dietz and Judy Lundy on May 27, 2010 and is headquartered in Rochester, MN.

Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME.

New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning.

Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ.

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands.

City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Therasis, Inc. develops oncology drugs. It offers oncology therapeutics for use as single agents or in combination therapy. The firm's proprietary technology, the Therasis Filter, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers and this platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. The company was founded by Owen A. O'Connor and Riccardo Dalla-Favera in 2007 and is headquartered in New York, NY.

Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong.

PlanetVerify Ltd. provides electronic monetary transactions services. The company was founded by Owen Sorensen, Farmar Sean, and Heather Kennedy in 2013 and is headquartered in Dublin, Ireland.

Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA.

Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.

Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.

Esanik Therapeutics, Inc. develops treatments for cancer.

Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA.

MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.

iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada.